Skip to Main content Skip to Navigation
Journal articles

Larger number of invariant natural killer T cells in PBSC allografts correlates with improved GVHD-free and progression-free survival

Abstract : Key Points • Higher dose of invariant NKT cells within PBSC allograft is associated with an improved GPFS. We studied the impact of a set of immune cells contained within granulocyte colony-stimulating factor–mobilized peripheral blood stem cell grafts (na¨ıvena¨ıve and memory T-cell subsets, B cells, regulatory T cells, invariant natural killer T cells [iNKTs], NK cells, and dendritic cell subsets) in patients (n 5 80) undergoing allogeneic stem cell trans-plantation (SCT), using the composite end point of graft-versus-host disease (GVHD)-free and progression-free survival (GPFS) as the primary end point. We observed that GPFS incidences in patients receiving iNKT doses above and below the median were 49% vs 22%, respectively (P 5 .007). In multivariate analysis, the iNKT dose was the only parameter with a significant impact on GPFS (hazard ratio 5 0.48; 95% confidence interval, 0.27-0.85; P 5 .01). The incidences of severe grade III to IV acute GVHD and National Institutes of Health grade 2 to 3 chronic GVHD (12% and 16%, respectively) were low and associated with the use of antithymocyte globulin in 91% of patients. No difference in GVHD incidence was reported according to the iNKT dose. In conclusion, a higher dose of iNKTs within the graft is associated with an improved GPFS. These data may pave the way for prospective and active interventions aiming to manipulate the graft content to improve allo
Document type :
Journal articles
Complete list of metadatas

Cited literature [38 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-01408681
Contributor : Elizabeth Bernardo <>
Submitted on : Monday, December 5, 2016 - 11:28:01 AM
Last modification on : Wednesday, September 16, 2020 - 10:43:31 AM
Long-term archiving on: : Tuesday, March 21, 2017 - 2:36:59 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Citation

Florent Malard, Myriam Labopin, Patrice Chevallier, Thierry Guillaume, Alix Duquesne, et al.. Larger number of invariant natural killer T cells in PBSC allografts correlates with improved GVHD-free and progression-free survival. Blood, American Society of Hematology, 2016, 127, pp.1828 - 1835. ⟨10.1182/blood-2015-12-688739⟩. ⟨inserm-01408681⟩

Share

Metrics

Record views

283